Neurosurgery — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Neurosurgery is the surgical specialty dedicated to the diagnosis, surgical management, and rehabilitation of disorders affecting the brain, spinal cord, spinal column, peripheral nerves, and cerebrovascular system. The specialty encompasses the most technically demanding procedures in medicine, requiring detailed knowledge of neuroanatomy, neurophysiology, and the critical relationships between operative targets and eloquent brain structures that control movement, language, cognition, and bodily function. Modern neurosurgery has been transformed by technological advances: intraoperative neuronavigation (GPS-like spatial tracking using pre-operative MRI), intraoperative MRI and ultrasound, neurophysiological monitoring (motor and somatosensory evoked potentials, electrocorticography), endoscopic and minimally invasive approaches, stereotactic radiosurgery (Gamma Knife, CyberKnife, LINAC radiosurgery), and robotic assistance have expanded the boundaries of safe surgical intervention. Major subspecialties include neuro-oncology (brain and spinal tumour surgery), cerebrovascular surgery (aneurysm clipping, AVM resection, carotid endarterectomy), functional neurosurgery (deep brain stimulation for Parkinson's disease, epilepsy surgery), spine surgery (disc disease, stenosis, spinal fusion), paediatric neurosurgery, and skull base surgery. Neurosurgery is performed in dedicated neuroscience centres with 24-hour neurosurgical and neuro-intensive care capability, typically part of major academic medical centres.

This treatment represents an important component of modern medical management, supported by clinical evidence from multiple randomised controlled trials and systematic reviews. Treatment protocols are continually refined based on emerging evidence to optimise patient outcomes while minimising treatment burden.

Patient suitability is assessed through a structured multidisciplinary evaluation incorporating clinical history, physical examination findings, and results of relevant investigations. Treatment planning considers the full clinical context including disease characteristics, patient comorbidities, functional status, and individual treatment goals to ensure the most appropriate therapeutic approach is selected for each patient.

Neurosurgical intervention is indicated when a structural brain or spinal condition causes or threatens to cause significant neurological deficit, when it is life-threatening, or when it is a curable condition that will cause permanent damage without surgical treatment. Brain tumour surgery is indicated for primary brain tumours (glioblastoma, meningioma, acoustic neuroma, pituitary adenoma, medulloblastoma) when resection can safely reduce tumour mass and improve neurological function or survival, and for metastatic brain tumours causing significant symptoms or mass effect in patients with controlled systemic disease. Cerebrovascular conditions: ruptured or unruptured intracranial aneurysms (surgical clipping or endovascular coiling prevents rebleeding); arteriovenous malformations (AVM) causing haemorrhage or intractable seizures; haematoma evacuation for large intracerebral or subdural haematoma causing mass effect and clinical deterioration; carotid endarterectomy for high-grade symptomatic carotid stenosis (reducing stroke risk). Spinal conditions: microdiscectomy for herniated nucleus pulposus causing radiculopathy or cauda equina syndrome; laminectomy and spinal fusion for stenosis causing myelopathy or neurogenic claudication; spinal tumour resection; traumatic spinal cord injury with fracture-dislocation or epidural haematoma. Functional: deep brain stimulation (DBS) for advanced Parkinson's disease unresponsive to medical management; epilepsy surgery for drug-resistant focal epilepsy with identified surgical lesion; trigeminal neuralgia microvascular decompression. Hydrocephalus: ventriculoperitoneal shunt insertion for obstructive hydrocephalus causing raised intracranial pressure. Each surgical decision is made by a multidisciplinary team weighing surgical risk against the natural history of the untreated condition.

The operative approach in neurosurgery depends entirely on the location and nature of the pathology. Craniotomy — the most fundamental neurosurgical technique — involves making a scalp incision, drilling burr holes, and using a craniotome to cut a bone flap that is temporarily removed to expose the dura mater (the outer brain covering). The dura is opened under operative microscope magnification, providing direct surgical access. Intraoperative neuronavigation (registration of pre-operative MRI/CT to the patient's head position) guides surgical trajectory to the tumour or vascular lesion with millimetre precision, while avoiding critical structures. Neurophysiological monitoring records motor and somatosensory evoked potentials throughout the procedure, providing real-time feedback on proximity to motor pathways. For tumours adjacent to eloquent cortex, awake craniotomy (performed under monitored anaesthesia care with an asleep-awake-asleep technique or sedation) allows direct intraoperative cortical mapping — the patient performs language or motor tasks while the surgeon applies electrical stimulation to identify and preserve eloquent areas. Following tumour resection, the bone flap is replaced and secured with titanium plates. Endoscopic neurosurgery — using an endoscope rather than operative microscope — is used for pituitary adenoma resection via the transsphenoidal approach (through the nose), third ventriculostomy for hydrocephalus, and intraventricular tumours. Spinal neurosurgery uses posterior, anterior, or lateral approaches depending on pathology location; microsurgical magnification is standard for disc surgery; pedicle screw and rod instrumentation provides spinal stability after decompression and fusion.

Neurosurgery offers the only curative or significantly disease-modifying treatment for many conditions. Benign tumour resection (meningioma, acoustic neuroma, pituitary adenoma) achieves local control rates of 80–95% with minimal recurrence and significant neurological improvement in the majority of patients — pituitary adenoma surgery normalises hypersecretion in 70–85% of functioning adenomas (Cushing's disease, acromegaly). For glioblastoma, maximal safe resection combined with temozolomide chemotherapy and radiotherapy extends median survival from approximately 3–4 months (with supportive care alone) to 14–16 months; complete resection achieves better outcomes than partial debulking. Aneurysm clipping prevents re-bleeding in over 98% of surgically treated aneurysms, eliminating the 1–2% annual rebleeding risk of unruptured aneurysms and the 35–40% 30-day mortality of ruptured aneurysm without treatment. Microdiscectomy relieves radiculopathy in 85–90% of carefully selected patients with disc herniation, typically providing immediate relief of leg pain. Deep brain stimulation for advanced Parkinson's disease reduces motor fluctuations, dyskinesia, and tremor by 50–70% in appropriately selected candidates, improving quality of life and independence significantly. Epilepsy surgery (temporal lobe resection for mesial temporal sclerosis) achieves seizure freedom (Engel Class I) in 60–80% of carefully selected patients — a transformative outcome for patients with drug-resistant epilepsy.

Neurosurgery carries significant risks that must be carefully weighed against the risks of leaving the condition untreated. Neurological deficit — new or worsened motor, sensory, language, or cognitive impairment — is the most feared consequence and varies from under 1% for elective spinal disc surgery to 10–30% for complex skull base or eloquent cortex brain tumour operations, depending on tumour location and the surgeon's experience. Stroke (ischaemic or haemorrhagic) is a risk of all intracranial procedures; rates are procedure-specific. Surgical site infection — wound infection or, more seriously, meningitis or cerebral abscess — occurs in 1–5% of cranial procedures and requires systemic antibiotic treatment and occasionally washout. Cerebrospinal fluid (CSF) leak (rhinorrhoea or wound leak) follows 2–5% of intracranial and spinal procedures, typically managed conservatively or with lumbar drain. Haematoma formation — extradural, subdural, or intracerebral — requiring return to theatre occurs in under 2% of cranial cases. Cerebral oedema is managed with corticosteroids (dexamethasone) and, if severe, osmotherapy. Seizures occur in 5–20% of patients after supratentorial tumour surgery and are managed with anticonvulsant medication. In spinal surgery: dural tear (causing CSF leak) occurs in 1–5%; nerve root injury causing new radiculopathy in under 1%; implant failure (screw loosening or breakage) in 1–5% at 2 years; adjacent segment disease (degeneration above or below fused levels) is a long-term concern after spinal fusion.

Recovery from neurosurgery is highly variable depending on the procedure, patient age, and pre-operative neurological status. Following craniotomy, patients are admitted to the neurosurgical intensive care unit (NICU) for 24–72 hours for continuous neurological monitoring, blood pressure management, and early detection of complications. Most patients are step-down to the neurosurgical ward within 2–3 days. Physiotherapy, occupational therapy, and speech and language therapy begin in the acute setting to maximise early neurological recovery. Most craniotomy patients are discharged within 5–10 days; complex skull base or posterior fossa procedures may require 7–14 days. Oral dexamethasone is prescribed to reduce peri-operative cerebral oedema and is tapered over 2–4 weeks. Antiepileptic drugs are continued for 3–6 months after supratentorial tumour surgery in most centres. Driving is prohibited for a minimum of 6 months after intracranial tumour surgery or epilepsy procedures (national licensing regulations vary). Return to desk work occurs at 4–8 weeks; physical labour at 12 weeks. Neurological rehabilitation — physiotherapy for motor deficits, speech and language therapy for dysphasia, occupational therapy for activities of daily living — may be required for several months in patients with post-operative deficits. After spinal surgery: microdiscectomy patients typically walk the same day and are discharged in 1–2 days, returning to light work in 4–6 weeks; spinal fusion requires 6–12 weeks recovery with restrictions on bending, lifting, and twisting. Outpatient neurosurgical follow-up at 4–6 weeks includes wound review and neurological assessment; MRI surveillance for brain tumours typically at 3 months and then 6-monthly.